PRLD
#3261
Prelude Therapeutics Incorporated - Common Stock
3.7 4 USD
-0.04%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-3.86%
Variazione Mensile
-18.70%
Variazione di 6 mesi
-16.52%
Variazione Annuale
+194.49%
Chiusura Precedente
3.8 9
Open
3.9 1
Minimo
3.7 4
Massimo
3.9 4
Financials
2024
Current report, 08 Apr 2024
Prelude Therapeutics Inc current report, 08 April 2024
8-K
Quarterly report, Q1 FY2024
Prelude Therapeutics Inc quarterly report, Q1 FY2024
10-Q
Current report, 15 Feb 2024
Prelude Therapeutics Inc current report, 15 February 2024
8-K
2023
Annual report, FY2023
Prelude Therapeutics Inc annual report, FY2023
10-K
Current report, 11 Dec 2023
Prelude Therapeutics Inc current report, 11 December 2023
8-K
Current report, 01 Nov 2023
Prelude Therapeutics Inc current report, 01 November 2023
8-K
Quarterly report, Q3 FY2023
Prelude Therapeutics Inc quarterly report, Q3 FY2023
10-Q
Current report, 03 Aug 2023
Prelude Therapeutics Inc current report, 03 August 2023
8-K
Quarterly report, Q2 FY2023
Prelude Therapeutics Inc quarterly report, Q2 FY2023
10-Q
Current report, 16 Jun 2023
Prelude Therapeutics Inc current report, 16 June 2023
8-K